Oliver Luxxe Assets LLC Abb Vie Inc. Transaction History

Oliver Luxxe Assets LLC

$528 Million
Q3 2024

A detailed history of Oliver Luxxe Assets LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Oliver Luxxe Assets LLC holds 36,687 shares of ABBV stock, worth $6.15 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares

36,687

Previous 37,179 1.32%

Holding current value

$6.15 Million

Previous $6.38 Million 13.61%

% of portfolio

1.37%

Previous 1.39%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	SELL	$163.84 - $199.33 $80,609 - $98,070	-492 Reduced 1.32%	36,687 $7.24 Million
Q2 2024 Aug 13, 2024	BUY	$154.79 - $180.76 $4,179 - $4,880	27 Added 0.07%	37,179 $6.38 Million
Q1 2024 Apr 18, 2024	SELL	$159.82 - $182.1 $46,827 - $53,355	-293 Reduced 0.78%	37,152 $6.77 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $30,822 - $34,713	224 Added 0.6%	37,445 $5.8 Million
Q3 2023 Nov 09, 2023	BUY	$133.59 - $154.65 $70,669 - $81,809	529 Added 1.44%	37,221 $5.55 Million
Q2 2023 Aug 01, 2023	SELL	$132.51 - $164.9 $29,549 - $36,772	-223 Reduced 0.6%	36,692 $4.94 Million
Q1 2023 Apr 19, 2023	SELL	$144.61 - $166.54 $440,626 - $507,447	-3,047 Reduced 7.62%	36,915 $5.88 Million
Q4 2022 Jan 30, 2023	SELL	$138.31 - $165.87 $1,106 - $1,326	-8 Reduced 0.02%	39,962 $6.46 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $86,431 - $99,130	644 Added 1.64%	39,970 $5.36 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $84,223 - $107,075	612 Added 1.58%	39,326 $6.02 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $300,650 - $373,022	-2,278 Reduced 5.56%	38,714 $6.28 Million
Q4 2021 Feb 16, 2022	BUY	$107.43 - $135.93 $48,021 - $60,760	447 Added 1.1%	40,992 $5.55 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $413,576 - $469,471	3,887 Added 10.6%	40,545 $4.37 Million
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $317,523 - $353,739	3,018 Added 8.97%	36,658 $4.13 Million
Q1 2021 Apr 29, 2021	BUY	$102.3 - $112.62 $396,924 - $436,965	3,880 Added 13.04%	33,640 $3.64 Million
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $616,955 - $832,955	7,665 Added 34.69%	29,760 $3.24 Million
Q3 2020 Oct 20, 2020	BUY	$85.91 - $100.83 $310,994 - $365,004	3,620 Added 19.59%	22,095 $1.94 Million
Q2 2020 Aug 12, 2020	BUY	$73.37 - $98.18 $69,701 - $93,271	950 Added 5.42%	18,475 $1.81 Million
Q1 2020 Apr 21, 2020	BUY	$64.5 - $97.79 $1.13 Million - $1.71 Million	17,525 New	17,525 $1.38 Million
Q3 2019 Oct 15, 2019	SELL	$62.98 - $75.72 $1.99 Million - $2.39 Million	-31,583 Closed	0 $0
Q2 2019 Jul 10, 2019	BUY	$65.7 - $83.98 $73,124 - $93,469	1,113 Added 3.65%	31,583 $2.25 Million
Q1 2019 May 01, 2019	SELL	$77.14 - $90.79 $123,115 - $144,900	-1,596 Reduced 4.98%	30,470 $2.46 Million
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $57,531 - $70,951	-739 Reduced 2.25%	32,066 $2.96 Million
Q3 2018 Oct 10, 2018	BUY	$88.91 - $98.84 $268,686 - $298,694	3,022 Added 10.15%	32,805 $3.1 Million
Q1 2018 Apr 17, 2018	BUY	$92.01 - $123.21 $2.74 Million - $3.67 Million	29,783 New	29,783 $2.82 Million

Others Institutions Holding ABBV

# of Institutions

3,846

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oliver Luxxe Assets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oliver Luxxe Assets LLC with notifications on news.

Account

Oliver Luxxe Assets LLC Abb Vie Inc. Transaction History